バイオマーカーの世界市場:種類別(安全性、有効性、検証)、用途別(診断、医薬品開発、個別化医療)、疾患別

◆英語タイトル:Biomarkers Market Size, Share & Trends Analysis Report By Type (Safety, Efficacy, Validation), By Application (Diagnostic, Drug Development, Personalized Medicine), By Disease, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY034
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年3月5日
◆ページ数:200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、バイオマーカーの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、種類別(安全性、有効性、検証)分析、用途別(診断、医薬品開発、個別化医療)分析、疾患別(がん、循環器疾患、神経疾患免疫疾患、その他)分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・競争分析
・バイオマーカーの世界市場:種類別(安全性、有効性、検証)
・バイオマーカーの世界市場:用途別(診断、医薬品開発、個別化医療)
・バイオマーカーの世界市場:疾患別(がん、循環器疾患、神経疾患免疫疾患、その他)
・バイオマーカーの世界市場:地域別
・競争状況
【レポートの概要】

The global biomarkers market size is expected to reach over USD 129.4 billion by 2027, according to a new study conducted by Grand View Research Inc. It is anticipated to exhibiting a CAGR of 13.7%, during the forecast period. Factors, such as increasing collaborations and funds for R&D activities, rising consumer awareness, a widening patient base, and technological advancements collectively augmenting market growth.

The drug discovery segment contributed the highest revenue in 2019. Pharmaceutical companies focus on extensive R&D initiatives for the development of targeted therapeutics. Coordinated strategic efforts on biomarker development remain a searing trend among drug manufacturers, academic research institutions, commercial R&D organizations, nonprofitable health foundations, and federal government biomedical regulatory and research agencies.

North America continued to lead the biomarkers market in 2019, driven by an amplifying demand for personalized medicines, high disease prevalence, and proactive government initiatives. It is expected to maintain its lead over the forecast period. Asia Pacific is positioned to witness the fastest CAGR, over the forecast period, spearheaded by India.

Some key market players include Abbott; F. Hoffmann-La Roche Ltd.; Qiagen; Siemens Healthcare Private Limited; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Johnson & Johnson Services, Inc; Agilent Technologies, Inc.; and Epigenomics AG. The players are developing novel kits and therapies and drugs to target population in the areas with high unmet clinical needs.

Further key findings from the study suggest:

• Safety biomarkers captured more than 41% market share in 2019, driven by increasing awareness regarding routine healthcare checkups and reduction in drug attrition

• Validation biomarkers is expected to demonstrate the fastest CAGR through to 2027

• Personalized medicine is likely to expand at a CAGR of 14.8% over the forecast period due to consumer awareness and preferences

• Cancer dominated the disease segment in 2019, driven by a high disease burden and presence of a strong pipeline

• Cardiovascular disease segment is projected to witness the fastest growth in the forthcoming years, supported by the growing obese population base and sedentary lifestyles

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources & third party perspectives
1.3.4. Primary research
1.4. Information Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biomarkers Market Variables, Trends & Scope
3.1. Biomarkers Market Lineage outlook
3.1.1. Clinical diagnostics market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Framework
3.3.1. Reimbursement framework
3.3.2. Standards & compliances
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic diseases
3.4.1.2. Technological advancements
3.4.1.3. Funding for biomrkers
3.4.2. Market restraint analysis
3.4.2.1. Reimbursement policies
3.5. Biomarkers Market Analysis Tools
3.5.1. Industry analysis – Porter’s
3.5.1.1. Supplier power: (High due to large number of manufacturers)
3.5.1.2. Buyer power: (Moderate due tolong-term contracts with manufacturers)
3.5.1.3. Substitution threat: (Moderate due to no/less external substitutes)
3.5.1.4. Threat from new entrant: (Moderate due to limited number of new players)
3.5.1.5. Competitive rivalry: (High due to mergers & acquisitions by major players)
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Environmental landscape
3.5.2.3. Social landscape
3.5.2.4. Technology landscape
3.5.2.5. Legal landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.3.1. Joint ventures
3.5.3.2. Mergers & acquisitions
3.5.3.3. Licensing & partnership
3.5.3.4. Technology collaborations
3.5.3.5. Strategic divestments
Chapter 4. Biomarkers Market – Competitive Analysis
4.1. Recent Developments & Impact Analysis, By Key Market Participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Vendor Landscape
4.3.1. List of key distributors and channel partners
4.3.2. Key company market share analysis, 2019
4.4. Public Companies
4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.4.2. Company market share
4.4.3. Competitive dashboard analysis
4.4.4. Market differentiators
4.4.5. Synergy analysis: Major deals & strategic alliances
4.5. Private Companies
4.5.1. List of key emerging companies
4.5.2. Regional network map
4.5.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5. Biomarkers Market: Type Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Type Market Share Analysis, 2019 & 2027
5.3. Biomarkers Market, by Type, 2015 to 2027
5.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
5.4.1. Safety
5.4.1.1 Safety market, 2015 – 2027 (USD Million)
5.4.2. Efficacy
5.4.2.1 Efficacy market, 2015 – 2027 (USD Million)
5.4.3. Validation
5.4.3.1 Validation market, 2015 – 2027 (USD Million)
Chapter 6. Biomarkers Market: Application Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Application Market Share Analysis, 2019 & 2027
6.3. Biomarkers Market, by Application, 2015 to 2027
6.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
6.4.1. Diagnostics
6.4.1.1 Diagnostics market, 2015 – 2027 (USD Million)
6.4.2. Drug development
6.4.2.1 Drug development market, 2015 – 2027 (USD Million)
6.4.3. Personalized medicine
6.4.3.1 Personalized medicine market, 2015 – 2027 (USD Million)
Chapter 7. Biomarkers Market: Disease Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Disease Market Share Analysis, 2019 & 2027
7.3. Biomarkers Market, by Disease, 2015 to 2027
7.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
7.4.1. Cancer
7.4.1.1 Cancer market, 2015 – 2027 (USD Million)
7.4.2. Cardiovascular disease
7.4.2.1 Cardiovascular disease market, 2015 – 2027 (USD Million)
7.4.3. Neurological disease
7.4.3.1 Neurological disease market, 2015 – 2027 (USD Million)
7.4.4. Immunological disease
7.4.4.1 Immunological disease market, 2015 – 2027 (USD Million)
7.4.5. Others
7.4.5.1 Others market, 2015 – 2027 (USD Million)
7.5. Disease Market, by Type, 2015 – 2027:
7.5.1. Cancer
7.5.1.1 Safety
7.5.1.1.1 Cancer biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.1.2 Efficacy
7.5.1.2.1 Cancer biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.1.3 Validation
7.5.1.3.1 Cancer biomarkers market, by validation, 2015 – 2027 (USD Million)
7.5.2. Cardiovascular diseases
7.5.2.1 Safety
7.5.2.1.1 Cardiovascular biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.2.2 Efficacy
7.5.2.2.1 Cardiovascular biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.2.3 Validation
7.5.2.3.1 Cardiovascular biomarkers market, by validation, 2015 – 2027 (USD Million)
7.5.3. Neurological disease
7.5.3.1 Safety
7.5.3.1.1 Neurological biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.3.2 Efficacy
7.5.3.2.1 Neurological biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.3.3 Validation
7.5.3.3.1 Neurological biomarkers market, by validation, 2015 – 2027 (USD Million)
7.5.4. Imunological disease
7.5.4.1 Safety
7.5.4.1.1 Imunological biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.4.2 Efficacy
7.5.4.2.1 Imunological biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.4.3 Validation
7.5.4.3.1 Imunological biomarkers market, by validation, 2015 – 2027 (USD Million)
7.5.5. Others
7.5.5.1 Safety
7.5.5.1.1 Other biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.5.2 Efficacy
7.5.5.2.1 Other biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.5.3 Validation
7.5.5.3.1 Other biomarkers market, by validation, 2015 – 2027 (USD Million)
Chapter 8 Biomarkers Market: Regional Estimates & Trend Analysis, by Type, Application, & Disease
8.1 Biomarkers Market: Regional Movement Analysis, 2019 & 2027
8.2 Biomarkers Market: Leading Players, 2019:
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4 North America
8.4.1 North America biomarkers market, 2015 – 2027 (USD Million)
8.4.2 U.S.
8.4.2.1 U.S. biomarkers market, 2015 – 2027 (USD Million)
8.4.3 Canada
8.4.3.1 Canada biomarkers market, 2015 – 2027 (USD Million)
8.5. Europe
8.5.1 Europe biomarkers market, 2015 – 2027 (USD Million)
8.5.2 U.K.
8.5.2.1 U.K. biomarkers market, 2015 – 2027 (USD Million)
8.5.3 Germany
8.5.3.1 Germany biomarkers market, 2015 – 2027 (USD Million)
8.5.4 Spain
8.5.4.1 Spain biomarkers market, 2015 – 2027 (USD Million)
8.5.5 France
8.5.5.1 France biomarkers market, 2015 – 2027 (USD Million)
8.5.6 Italy
8.5.6.1 Italy biomarkers market, 2015 – 2027 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific biomarkers market, 2015 – 2027 (USD Million)
8.6.2 Japan
8.6.2.1 Japan biomarkers market, 2015 – 2027 (USD Million)
8.6.3 India
8.6.3.1 India biomarkers market, 2015 – 2027 (USD Million)
8.6.4 South Korea
8.6.4.1 South Korea biomarkers market, 2015 – 2027 (USD Million)
8.6.5 China
8.6.5.1 China biomarkers market, 2015 – 2027 (USD Million)
8.6.6 Australia
8.6.6.1 Australia biomarkers market, 2015 – 2027 (USD Million)
8.7 Latin America
8.7.1 Latin America biomarkers market, 2015 – 2027 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil biomarkers market, 2015 – 2027 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico biomarkers market, 2015 – 2027 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina biomarkers market, 2015 – 2027 (USD Million)
8.8 MEA
8.8.1 MEA biomarkers market, 2015 – 2027 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa biomarkers market, 2015 – 2027 (USD Million)
8.8.3 United Arab Emirates
8.8.3.1 United Arab Emirates biomarkers market, 2015 – 2027 (USD Million)
8.8.4 Saudi Arabia
8.8.4.1 Saudi Arabia biomarkers market, 2015 – 2027 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Heat Map Analysis of Private Companies
9.2.1 Company size
9.2.2 Distribution network
9.2.3 Product portfolio
9.2.4 Segment coverage
9.2.5 Geographic presence
9.2.6 Collaborations
9.2.7 Conclusion
9.3 F-Hoffman La Roche Ltd.
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 Abbott
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 Epigenomics AG
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 General Electric Company
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 Johnson & Johnson
9.7.1 Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Thermo Fisher Scientific, Inc.
9.8.1 Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.9 Bio-Rad Laboratories, Inc.
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Siemens Healthcare Private Limited
9.10.1 Company overview
9.10.1 Financila performance
9.10.2 Product benchmarking
9.10.3 Strategic initiatives
9.11 Qiagen
9.11.1 Company Overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives

List of Tables

TABLE 1 State wise naturopathy & yoga practitioners, India
TABLE 2 Adoption of CAM in the U.S., by diseases
TABLE 3 North America complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 4 North America botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 5 North America mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 6 North America. energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 7 North America magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 8 North America complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 9 U.S. complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 10 U.S. botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 11 U.S. mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 12 U.S. energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 13 U.S. magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 14 U.S. complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 15 Canada complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 16 Canada botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 17 Canada mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 18 Canada energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 19 Canada magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 20 Canada complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 21 Europe complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 22 Europe botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 23 Europe mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 24 Europe energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 25 Europe magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 26 Europe complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 27 Germany complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 28 Germany botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 29 Germany mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 30 Germany energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 31 Germany magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 32 Germany complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 33 France complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 34 France botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 35 France mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 36 France energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 37 France magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 38 France complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 39 U.K. complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 40 U.K. botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 41 U.K. mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 42 U.K. energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 43 U.K. magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 44 U.K. complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 45 Switzerland complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 46 Switzerland botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 47 Switzerland mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 48 Switzerland energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 49 Switzerland magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 50 Switzerland complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 51 Austria complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 52 Austria botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 53 Austria mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 54 Austria energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 55 Austria magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 56 Austria complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 57 Spain complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 58 Spain botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 59 Spain mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 60 Spain energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 61 Spain magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 62 Spain complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 63 Norway complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 64 Norway botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 65 Norway mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 66 Norway energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 67 Norway magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 68 Norway complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 69 Denmark complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 70 Denmark botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 71 Denmark mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 72 Denmark energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 73 Denmark magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 74 Denmark complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 75 Sweden complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 76 Sweden botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 77 Sweden mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 78 Sweden energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 79 Sweden magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 80 Sweden complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 81 Belgium complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 82 Belgium botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 83 Belgium mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 84 Belgium energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 85 Belgium magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 86 Belgium complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 87 Netherlands complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 88 Netherlands botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 89 Netherlands mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 90 Netherlands energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 91 Netherlands magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 92 Netherlands complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 93 Ireland complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 94 Ireland botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 95 Ireland mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 96 Ireland energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 97 Ireland magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 98 Ireland complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 99 Asia Pacific complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 100 Asia Pacific botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 101 Asia Pacific mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 102 Asia Pacific energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 103 Asia Pacific magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 104 Asia Pacific complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 105 China complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 106 China botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 107 China mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 108 China energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 109 China magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 110 China complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 111 India complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 112 India botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 113 India mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 114 India energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 115 India magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 116 India complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 117 Japan complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 118 Japan botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 119 Japan mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 120 Japan energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 121 Japan magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 122 Japan complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 123 Australia complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 124 Australia botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 125 Australia mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 126 Australia energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 127 Australia magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 128 Australia complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 129 New Zealand complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 130 New Zealand botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 131 New Zealand mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 132 New Zealand energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 133 New Zealand magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 134 New Zealand complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 135 Singapore complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 136 Singapore botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 137 Singapore mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 138 Singapore energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 139 Singapore magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 140 Singapore complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 141 Hong Kong complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 142 Hong Kong botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 143 Hong Kong mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 144 Hong Kong energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 145 Hong Kong magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 146 Hong Kong complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 147 Latin America complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 148 Latin America botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 149 Latin America mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 150 Latin America energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 151 Latin America magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 152 Latin America complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 153 Brazil complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 154 Brazil botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 155 Brazil mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 156 Brazil energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 157 Brazil magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 158 Brazil complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 159 Mexico complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 160 Mexico botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 161 Mexico mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 162 Mexico energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 163 Mexico magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 164 Mexico complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 165 Argentina complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 166 Argentina botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 167 Argentina mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 168 Argentina energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 169 Argentina magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 170 Argentina complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 171 MEA complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 172 MEA botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 173 MEA mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 174 MEA energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 175 MEA magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 176 MEA complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 177 UAE complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 178 UAE botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 179 UAE mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 180 UAE energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 181 UAE magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 182 UAE complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 183 South Africa complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 184 South Africa botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 185 South Africa mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 186 South Africa energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 187 South Africa magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 188 South Africa complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 189 Israel complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 190 Israel botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 191 Israel mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 192 Israel energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 193 Israel magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 194 Israel complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market model for CAM market
FIG. 8 Penetration of CAM providers regulated by Member States
FIG. 9 Growth in the number of Member States with a national policy on CAM, 1999-2018
FIG. 10 Member states with policy on CAM & herbal regulation
FIG. 11 Market segmentation & scope
FIG. 12 Market summary
FIG. 13 Market trends & outlook
FIG. 14 Penetration & growth prospect mapping, by intervention, 2019
FIG. 15 Market driver relevance analysis (Current & future impact)
FIG. 16 Most commonly adopted CAM, the U.S.
FIG. 17 Penetration of complementary and alternative medicine in the U.S., adult versus children
FIG. 18 Penetration of complementary and alternative medicine in the U.S., by age
FIG. 19 Usage growth rate in complementary and alternative therapies in Canada, 1997-2016
FIG. 20 Market restraint relevance analysis (Current & future impact)
FIG. 21 Market opportunity relevance analysis (Current & future impact)
FIG. 22 Market challenges relevance analysis (Current & future impact)
FIG. 23 Impact analysis by key market participants
FIG. 24 Company market position analysis
FIG. 25 Complementary and alternate medicine market: Intervention outlook key takeaways
FIG. 26 Complementary and alternative medicine market: Intervention movement analysis
FIG. 27 Global botanicals complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 28 Global ayurveda complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 29 Global naturopathy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 30 Global homeopathy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 31 Global mind/ body healing complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 32 Global yoga complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 33 Global meditation complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 34 Global energy healing complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 35 Global Eden energy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 36 Global other energy healing complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 37 Global chakra healing complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 38 Global hypnotherapy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 39 Global kinesiology complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 40 Global magnetic intervention complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 41 Global magnetic resonance therapy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 42 Global bio-magnetic therapy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 43 Global accupunture complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 44 Complementary and alternate medicine market: Distribution method outlook key takeaways
FIG. 45 Complementary and alternative medicine market: Distribution method movement analysis
FIG. 46 Global direct sales-based complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 47 Global E-sales-based complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 48 Global distance correspondence-based complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 49 Regional market place: Key takeaways
FIG. 50 Regional outlook, 2019 & 2027
FIG. 51 North America complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 52 U.S. complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 53 Canada complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 54 Europe complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 55 Germany complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 56 France complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 57 U.K. complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 58 Switzerland complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 59 Austria complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 60 Spain complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 61 Norway complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 62 Denmark complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 63 Sweden complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 64 Belgium complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 65 Netherlands complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 66 Ireland complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 67 Asia Pacific complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 68 China complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 69 India complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 70 Japan complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 71 Australia complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 72 New Zealand complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 73 Singapore complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 74 Hong Kong complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 75 Latin America complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 76 Brazil complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 77 Mexico complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 78 Argentina complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 79 MEA complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 80 UAE complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 81 South Africa complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 82 Israel complementary and alternative medicine market, 2016 - 2027 (USD Billion)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[バイオマーカーの世界市場:種類別(安全性、有効性、検証)、用途別(診断、医薬品開発、個別化医療)、疾患別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆